CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in ...

Vir Biotechnology, Inc. (VIR) has already been able to initiate its late-stage ECLIPSE program, which is using the combination of monoclonal antibody tobevibart in combination with small interfering ...

Join 19 News for extensive coverage of the 2024 Total Solar Eclipse starting on Monday, April 8, with 19 News at Noon. 19 News will be live with LIGHTS OUT IN THE LAND coverage from locations all over ...

ECLIPSE ABOUT WHAT SCIENTISTS ARE LOOKING FORWARD TO. WE ARE JUST DAYS AWAY FROM A RARE CELESTIAL EVENT A TOTAL ECLIPSE OF THE SUN ON APRIL 8TH. MORE THAN 31 MILLION PEOPLE WILL BE IN THE PATH OF ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

The sun is about to pull another disappearing act across North America, turning day into night during a total solar eclipse.The peak spectacle on April 8 will last up to 4 minutes, 28 seconds in the ...